Other languages Zynex, Inc.

Equities

Real-time Estimate Cboe BZX Other stock markets 18:09:55 29/04/2024 BST			5-day change	1st Jan Change
11.46 ^USD	+2.19%		+3.14%	+5.51%

03-01	RBC Raises Price Target on Zynex to $15 From $13, Keeps Outperform Rating	MT
02-29	Zynex, Inc. Provides Earnings Guidance First Quarter and Full Year 2024	CI

Zynex, Inc. Provides Earnings Guidance First Quarter and Full Year 2024	02-29
Zynex, Inc. announces an Equity Buyback for $20 million worth of its shares.	02-29
Zynex, Inc. Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2023	02-29
Zynex, Inc. authorizes a Buyback Plan.	02-28
Zynex, Inc. Introduces New Products	02-20
Zynex Receives US FDA Approval for Muscle Stimulation Device	02-06
Zynex, Inc. Receives FDA Clearance for its Next Generation NMES Device	02-06
Zynex Submits FDA Application for M-Wave Neuromuscular Electrical Stimulation Device	11-13
Zynex, Inc. Submits FDA Application for Its NMES Device	11-13
Zynex, Inc. announces an Equity Buyback for $20 million worth of its shares.	11-01
Zynex, Inc. authorizes a Buyback Plan.	10-31
Zynex Board Initiates Review of Strategic Options Including Sale, Merger	31/10/23
Zynex Announces Review of Strategic Alternatives	31/10/23
Zynex, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	26/10/23
Zynex, Inc. Provides Earnings Guidance for Fourth Quarter and Full Year of 2023	26/10/23
Sector Update: Health Care Stocks Gaining Late Afternoon	11/09/23
Sector Update: Health Care Stocks Higher Monday Afternoon	11/09/23
Zynex to Launch $10 Million Buyback Program	11/09/23
Zynex, Inc. announces an Equity Buyback for $10 million worth of its shares.	11/09/23
Zynex, Inc. authorizes a Buyback Plan.	10/09/23

No results for this search